Pharmaceutical Industry
How sham patents are hurting the pharma industry
Irish pharma sector quizzes European election candidates on innovation, sustainability, and regulation
ASPA webinar on combating counterfeiting in pharm industry
Report calls for changes to government’s interaction with drug-pricing board, pharmaceutical industry
Cracking the code of complex pharmaceuticals: Exploring Critical Quality Attributes in Peptides and Oligos.
Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts
CPHI North America 2024: Bringing Together Innovation in Pharma
Unveiling 10 Analyst Insights On Marinus Pharma
Drugs Licensed
Drug Licensed from Sanofi Becomes First FDA-Approved Therapy for Ultra-Rare Primary Immunodeficiency
Man charged in Monroe with illegally obtaining assortment of prescription drugs
New York TikToker charged with selling Ozempic, other misbranded weight loss drugs that caused "significant, life-threatening injuries"
Woman Who Sold Misbranded Ozempic on TikTok Faces Smuggling Charge
Six Lao arrested for transporting 121 kg of drugs into Vietnam
Canine Scout alerts officers to drugs in a vehicle, driver is detained
A surprise leader for April's largest TV drug ad spender as Otsuka, Lundbeck knock AbbVie from its perch
Some psychedelic drug users are stuck with unwelcome highs
Kan. man with no drivers license, caught transporting drugs
Drugs Patents
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
How sham patents are hurting the pharma industry
US challenges 'bogus' patents on Ozempic, other drugs in effort to spur competition
FTC cracking down on junk patents in drugs like Ozempic
FTC disputes new slate of Orange Book patents for weight loss, diabetes, asthma, and COPD drugs
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
Sanders Applauds FTC’s Efforts to Challenge ‘Junk’ Patents for Drugs Such as Ozempic
Can Machines Invent Drugs: Patent Law Seeks to Prioritize Human Innovation as Artificial Intelligence Inventions Rise
Drugs Generics
Shortages of generic drugs can’t be blamed solely on group purchasing organizations
The world is relying on the United States to get value-based drug pricing right
Can EU wean itself off essential drugs from China, India?
New bill would pay hospitals to stockpile drugs
Global generic drugs market to reach $671.5B by 2030, report finds
White House Plan To Curb Drug Shortages Doesn’t Address Generics’ Quality
Here Are the Fastest Ways to Save on Your Prescription Drugs
Scant drug ingredients linked to US generic-drug shortages in first 2 COVID years
Competition from 'skinny label' generics saved medicare billions, according to report
FDA Food and Drug Administration
Eating yogurt could help prevent one common disease, according to the FDA
FDA issues 510k clearance for US Medical Innovations’ ablation system
Eli Lilly Alzheimer’s drug gets FDA panel date after approval delay
Apple pushes into clinical trials with new FDA nod for Apple Watch
FDA Over-Regulation of Lab Tests Could Harm Patients
FDA Experts Weigh In On Incannex's CannQuit-O With Feedback On CBD As Treatment For Opioid Use Disorder
The FDA targets pharma’s grip on costly, toxic cancer drug dosages
FDA advisers to weigh first psychedelic therapy in early June
Durbin demands FDA testimony on unauthorized vape sales
Pharmaceutical Companies
How sham patents are hurting the pharma industry
Private companies account for 47% of Cosmo Pharmaceuticals N.V.'s (VTX:COPN) ownership, while individual investors account for 37%
Bell-Kenz Pharma Inc. to file cyberlibel vs. individuals spreading 'malicious accusations'
Indian Pharmaceutical Alliance Calls for a Stronger U.S.-India Partnership for Affordable Medicine
Sell Rating on Vertex Pharmaceuticals Amid Non-Recurring Gains and Overstated Sales
Chief executive of pharmaceutical company parts ways with business
Model N Introduces New Rebate Enhancement, as Pharma Companies Prepare for Impact from the Inflation Reduction Act
Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
Pharma’s corporate reputation begins to slide following COVID surge